We are guided and inspired by

our vision

About Royal Philips


Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2017 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries.

Business highlights in Q1

Philips launches digital Ingenia Elition MR solution, delivering premium digital image quality up to 50% faster

Philips provides University of Ottawa Heart Institute with innovative health technology solutions for their expanded cardiovascular care facility

Philips continues to change the face of sleep apnea with latest addition to the DreamWear family

Philips results in Q3 2015

Philips in Q1 2018

Sales: 3.9 bln

Adjusted EBITA: 344 mln

Net income from continuing operations: 94 mln

Our transition towards a circular economy

Rethink the future

Changing the way we do business
Circular economy activities on Guardian Sustainable Business

Circular economy

Philips' transition to a circular economy
Annual report 2016

Annual Report 2017

Philips announcing its performance of 2017